Page last updated: 2024-09-05

lenalidomide and Activated Protein C Resistance

lenalidomide has been researched along with Activated Protein C Resistance in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brioli, A; Cavo, M; Pantani, L; Tacchetti, P; Zamagni, E; Zannetti, B	1

Other Studies

1 other study(ies) available for lenalidomide and Activated Protein C Resistance

Article	Year
Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis. Seminars in thrombosis and hemostasis, 2011, Volume: 37, Issue:3 Topics: Activated Protein C Resistance; Aged; Anticoagulants; Aspirin; Boronic Acids; Bortezomib; Dexamethasone; Humans; Immunologic Factors; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin	2011

Article

Year

Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis.

Seminars in thrombosis and hemostasis, 2011, Volume: 37, Issue:3

Topics: Activated Protein C Resistance; Aged; Anticoagulants; Aspirin; Boronic Acids; Bortezomib; Dexamethasone; Humans; Immunologic Factors; International Normalized Ratio; Lenalidomide; Multiple Myeloma; Proteasome Inhibitors; Pyrazines; Risk Factors; Thalidomide; Thrombosis; Venous Thromboembolism; Warfarin

2011